NFKB1 and acute kidney injury: Taken together, these results suggest that during SA‐AKI, increased H3K18la levels increase NF‐κB pathway activation and aggravate kidney injury, whereas a reduction in H3K18la has anti‐inflammatory effects with mitigation of kidney injury, contributing to the improvement of renal function after SA‐AKI.